IP Library › Granted Patent US 12,433,812
Granted Patent B2
US 12,433,812 · App. 19/010,846 · Granted Oct 7, 2025

Relocation module and methods for surgical equipment

Inventors: Scott D. Augustine (Deephaven, MN); Susan D. Augustine (Deephaven, MN); Garrett J. Augustine (Deephaven, MN); Brent M. Augustine (Savage, MN); Ryan S. Augustine (Minneapolis, MN); Randall C. Arnold (Minnetonka, MN)
Assignee: Augustine Biomedical + Design, LLC
A61G13/108A61B50/13A61B50/15A61M5/3134A61M5/31511A61M5/5013A61M16/06A61M16/18G16H20/10A61B5/4821A61B5/4848A61B46/10A61B2050/155A61B90/50A61M2005/2006A61M5/281A61M2005/5033A61M16/01B01D46/0093
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,812
App. No.
19/010,846
Granted
Oct 7, 2025
Kind
B2
Abstract

Modules for housing electronic and electromechanical medical equipment including a system to measure and record administration of one or more IV medications or fluids for IV administration.

Claims (48)

1. A module for acquiring and processing dose event and response event digital data, the module comprising:

one or more machine vision digital cameras for automatically acquiring dose event data including medication delivery data;

one or more physiological monitors for automatically acquiring response event data; and

processing circuitry and software in electrical communication with one or more machine vision digital cameras and the one or more physiological monitors, the processing circuitry and software configured to:

receive the dose event data from the one or more machine vision digital cameras;

receive the response event data from the one or more physiological monitors;

automatically add timestamps to the dose event data and to the response event data;

temporally correlate the dose event data with corresponding response event data;

identify, using artificial intelligence (AI) analytics of the processing circuitry and software, an expected physiologic response or an unexpected physiologic response of a patient based on the temporally correlated dose event data and response event data; and

provide alternative therapeutic suggestions when the unexpected physiologic response is identified based on one or more of a patient's medical history, medication orders, vital signs, or current medications.

2. The module of claim 1 , wherein the processing circuitry and software include memories and databases configured to do one or more of: receive physiological data, analyze physiological data, determine that physiological data is unexpected, create and send instructions to cause an alert to a provider or another user, and save a physiological event information to a storage device which may be a database.

3. The module of claim 1 , wherein at least a portion of the dose event data and the response event data are displayed on one or more display screens.

4. The module of claim 1 , wherein one or more of the dose event data and the response event data for the unexpected physiologic response, AI analytics, alerts and alternative therapeutic suggestions are configured to be displayed on one or more remote display screens to be used for one or more of remote supervision, remote consultation, remote monitoring or remote billing documentation.

5. The module of claim 1 , wherein the processing circuitry is configured to receive additional dose event data and additional response event data from electronic medical equipment in electrical communication with the processing circuitry of the module, wherein the additional dose event data and additional response event data relates to one or more of: physiologic monitors, fluid, gas and medication administration, ventilator settings, pressure off-loading, blood loss, urine output, and anesthesia related events.

6. A system for acquiring and processing dose event and response event digital data, the system comprising:

one or more machine vision digital cameras for acquiring dose event data based on one or more dose event including medication delivery event;

one or more physiologic monitors for acquiring response event data based on one or more response event; and

processing circuitry and software in electrical communication with the one or more machine vision digital cameras and the one or more physiologic monitors;

wherein the processing circuitry and software is configured to automatically add one or more timestamps to the dose event data and the response event data;

wherein the processing circuitry and software is configured to temporally correlate the dose event data with the response event data based on the one or more timestamps;

wherein the processing circuitry and software includes artificial intelligence (AI) configured to identify one or more expected physiologic response and or one or more unexpected physiologic response for the one or more dose event; and

wherein the processing circuitry and software is configured to provide alternative medication therapeutic suggestions when the one or more expected physiologic response and or one or more unexpected physiologic response is identified based on one or more of a patient's medical history, medication orders, vital signs, and current medications.

7. The system of claim 6 , wherein the processing circuitry and software includes memory and one or more database in communication with the processing circuitry and software and configured to do one or more of: receive physiological data, analyze physiological data, determine that physiological data is unexpected, create and send instructions to cause an alert to a provider or another user, and save a physiological event information to a storage device.

8. The system of claim 6 , wherein data representing the one or more dose event and the one or more response event are configured to be displayed on one or more display screens.

9. The system of claim 6 , wherein one or more of the dose event data and the response event data for the unexpected physiologic response, AI analytics, alerts and alternative therapeutic suggestions are configured to be displayed on one or more remote display screens to be used for one or more of remote supervision, remote consultation, remote monitoring or remote billing documentation.

10. The system of claim 6 , wherein the processing circuitry is configured to receive additional dose event and additional response event data from electronic medical equipment in electrical communication with the processing circuitry and software, wherein the additional dose event and additional response event data relates to one or more of: physiologic monitors, fluid, gas and medication administration, ventilator settings, pressure off-loading, blood loss, urine output, anesthesia related events, and airway management.

11. A module for acquiring and processing dose event and response event digital data, the module comprising:

one or more machine vision digital cameras for automatically acquiring dose event data including fluid delivery data;

one or more physiological monitors for automatically acquiring response event data; and

processing circuitry and software in electrical communication with one or more machine vision digital cameras and the one or more physiological monitors, the processing circuitry and software configured to:

receive the dose event data from the one or more machine vision digital cameras;

receive the response event data from the one or more physiological monitors;

automatically add timestamps to the dose event data and to the response event data;

temporally correlate the dose event data with corresponding response event data;

identify, using artificial intelligence (AI) analytics of the processing circuitry and software, an expected physiologic response or an unexpected physiologic response of a patient based on the temporally correlated dose event data and response event data; and

provide alternative therapeutic suggestions when the unexpected physiologic response is identified based on one or more of a patient's medical history, medication orders, vital signs, or current medications.

12. The module of claim 11 , wherein the processing circuitry and software include memories and databases configured to do one or more of: receive physiological data, analyze physiological data, determine that physiological data is unexpected, create and send instructions to cause an alert to a provider or another user, and save a physiological event information to a storage device which may be a database.

13. The module of claim 12 , wherein the storage device is a database.

14. The module of claim 11 , wherein at least a portion of the dose event data and the response event data are displayed on one or more display screens.

15. The module of claim 11 , wherein one or more of the dose event data and the response event data for the unexpected physiologic response, AI analytics, alerts and alternative therapeutic suggestions are configured to be displayed on one or more remote display screens to be used for one or more of remote supervision and remote consultation.

16. The module of claim 11 , wherein one or more of the dose event data and the response event data for the unexpected physiologic response, AI analytics, alerts and alternative therapeutic suggestions are configured to be displayed on one or more remote display screens to be used for one or more of remote monitoring and remote billing documentation.

17. The module of claim 11 , wherein the processing circuitry is configured to receive additional dose event data and additional response event data from electronic medical equipment in electrical communication with the processing circuitry of the module.

18. The module of claim 17 , wherein the processing circuitry is configured to temporally correlate the additional dose event data that corresponds with the additional response event data.

19. The module of claim 18 , wherein the processing circuitry is configured to:

temporally correlate the additional dose event data that corresponds with one or more of the dose event data and the response event data; and

temporally correlate the additional response event data that corresponds with one or more of the dose event data and the response event data.

20. The module of claim 19 , wherein identifying the expected physiologic response or an unexpected physiologic response of the patient is based on one or more of the temporally correlated additional dose event data and additional response event data.

21. The module of claim 17 , wherein the additional dose event data and additional response event data relate to one or more of: physiologic monitors; fluid, gas, or medication administration; ventilator settings; pressure off-loading; blood loss; urine output; and, anesthesia related events.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2025
From: AUGUSTINE, SCOTT D.; AUGUSTINE, SUSAN D.; AUGUSTINE, GARRETT J.; AUGUSTINE, BRENT M.; AUGUSTINE, RYAN S.; ARNOLD, RANDALL C.
To: AUGUSTINE BIOMEDICAL + DESIGN, LLC
Reel/Frame 069756/0826 →
Continuity (9)
Continuation 18203297 · May 30, 2023
Continuation 18099500 · Jan 20, 2023
Continuation 17862971 · Jul 12, 2022
Continuation 17550611 · Dec 14, 2021
Continuation 17332523 · May 27, 2021
Continuation 17167681 · Feb 4, 2021
Continuation In Part 17092681 · Nov 9, 2020
Continuation 16879406 · May 20, 2020
Related Publication 20250134742A1 · May 1, 2025
References Cited (400)
US 4105028A · Sadlier et al. · 1978 [cited by applicant]
US 4531956A · Howorth · 1985 [cited by applicant]
US 4967320A · Paschal · 1990 [cited by applicant]
US 5000737A · Free et al. · 1991 [cited by applicant]
US 5399007A · Marconet · 1995 [cited by applicant]
US 5409511A · Paul · 1995 [cited by applicant]
US 5516313A · Lumpkin · 1996 [cited by applicant]
US 5626140A · Feldman · 1997 [cited by applicant]
US 5655905A · Jaimes et al. · 1997 [cited by applicant]
US 5695536A · Fabrizi · 1997 [cited by applicant]
US 7494536B2 · Kang et al. · 2009 [cited by applicant]
US 7597731B2 · Palmerton et al. · 2009 [cited by applicant]
US 7674436B1 · Feldman et al. · 2010 [cited by applicant]
US 7753977B2 · Lyons et al. · 2010 [cited by applicant]
US 9603956B2 · Newham · 2017 [cited by applicant]
US 10312191B2 · Jung et al. · 2019 [cited by applicant]
US 10507153B2 · Augustine et al. · 2019 [cited by applicant]
US 10512191B2 · Augustine et al. · 2019 [cited by applicant]
US 10638638B2 · Augustine et al. · 2020 [cited by applicant]
US 10652577B2 · Thoreau et al. · 2020 [cited by applicant]
US 10653577B2 · Augustine et al. · 2020 [cited by applicant]
US 10702436B2 · Augustine et al. · 2020 [cited by applicant]
US 10869800B2 · Augustine et al. · 2020 [cited by applicant]
US 10888482B2 · Augustine et al. · 2021 [cited by applicant]
US 10993865B2 · Augustine et al. · 2021 [cited by applicant]
US 10993885B1 · Fernandez · 2021 [cited by applicant]
US 11035377B2 · Niwa et al. · 2021 [cited by applicant]
US 11045377B2 · Augustine et al. · 2021 [cited by applicant]
US 11160710B1 · Augustine et al. · 2021 [cited by applicant]
US 11173089B2 · Augustine et al. · 2021 [cited by applicant]
US 11219569B2 · Augustine et al. · 2022 [cited by applicant]
US 11219570B2 · Augustine et al. · 2022 [cited by applicant]
US 11285065B2 · Augustine et al. · 2022 [cited by applicant]
US 11291602B2 · Augustine et al. · 2022 [cited by applicant]
US 11426318B2 · Augustine et al. · 2022 [cited by applicant]
US 11426319B2 · Augustine et al. · 2022 [cited by applicant]
US 11426320B2 · Augustine et al. · 2022 [cited by applicant]
US 11432982B2 · Augustine et al. · 2022 [cited by applicant]
US 11432983B2 · Augustine et al. · 2022 [cited by applicant]
US 11446196B2 · Augustine et al. · 2022 [cited by applicant]
US 11523960B2 · Augustine et al. · 2022 [cited by applicant]
US 11564856B2 · Augustine et al. · 2023 [cited by applicant]
US 11583459B2 · Augustine et al. · 2023 [cited by applicant]
US 11583460B2 · Augustine et al. · 2023 [cited by applicant]
US 11583461B2 · Augustine et al. · 2023 [cited by applicant]
US 11583998B2 · Moon · 2023 [cited by applicant]
US 11642270B2 · Augustine et al. · 2023 [cited by applicant]
US 11648166B2 · Augustine et al. · 2023 [cited by applicant]
US 11654070B2 · Augustine et al. · 2023 [cited by applicant]
US 11666500B1 · Augustine et al. · 2023 [cited by applicant]
US 11679052B2 · Augustine et al. · 2023 [cited by applicant]
US 11701282B2 · Augustine et al. · 2023 [cited by applicant]
US 11744755B2 · Augustine et al. · 2023 [cited by applicant]
US 11752056B1 · Augustine et al. · 2023 [cited by applicant]
US 11766372B2 · Augustine et al. · 2023 [cited by applicant]
US 11766373B2 · Augustine et al. · 2023 [cited by applicant]
US 12023281B2 · Augustine et al. · 2024 [cited by applicant]
US 12121478B2 · Augustine et al. · 2024 [cited by applicant]
US 20010035702A1 · Murphy et al. · 2001 [cited by applicant]
US 20020074403A1 · Krichever et al. · 2002 [cited by applicant]
US 20020120211A1 · Wardle et al. · 2002 [cited by applicant]
US 20020183599A1 · Castellanos · 2002 [cited by applicant]
US 20030033790A1 · Hague · 2003 [cited by applicant]
US 20030141687A1 · Wixted et al. · 2003 [cited by applicant]
US 20030150328A1 · Hansson et al. · 2003 [cited by applicant]
US 20040103789A1 · Lan et al. · 2004 [cited by applicant]
US 20040176984A1 · White et al. · 2004 [cited by applicant]
US 20040247016A1 · Faries et al. · 2004 [cited by applicant]
US 20040249673A1 · Smith · 2004 [cited by applicant]
US 20040262146A1 · Platt et al. · 2004 [cited by applicant]
US 20050016982A1 · Campf et al. · 2005 [cited by applicant]
US 20050060974A1 · Palmerton et al. · 2005 [cited by applicant]
US 20050087256A1 · Clark · 2005 [cited by applicant]
US 20050097870A1 · Moshenrose · 2005 [cited by applicant]
US 20050261551A1 · Couvillon · 2005 [cited by applicant]
US 20060030820A1 · Alheidt et al. · 2006 [cited by applicant]
US 20060042205A1 · Kalous et al. · 2006 [cited by applicant]
US 20060144942A1 · Evans et al. · 2006 [cited by applicant]
US 20060163829A1 · Livengood et al. · 2006 [cited by applicant]
US 20060229506A1 · Castellanos · 2006 [cited by applicant]
US 20070199287A1 · Wiser · 2007 [cited by applicant]
US 20070225690A1 · Sekiguchi et al. · 2007 [cited by applicant]
US 20070253596A1 · Murata et al. · 2007 [cited by applicant]
US 20070260487A1 · Bartfeld et al. · 2007 [cited by applicant]
US 20080097315A1 · Miner et al. · 2008 [cited by applicant]
US 20080173178A1 · Metteer · 2008 [cited by applicant]
US 20080314978A1 · Fedorko et al. · 2008 [cited by applicant]
US 20090141947A1 · Kyyko et al. · 2009 [cited by applicant]
US 20090188311A1 · Cadieux et al. · 2009 [cited by applicant]
US 20100094262A1 · Tripathi et al. · 2010 [cited by applicant]
US 20100172550A1 · Gilley et al. · 2010 [cited by applicant]
US 20100191541A1 · Prokoski · 2010 [cited by applicant]
US 20100324380A1 · Perkins et al. · 2010 [cited by applicant]
US 20100324936A1 · Vishnubhatla et al. · 2010 [cited by applicant]
US 20110030560A1 · Bohlen et al. · 2011 [cited by applicant]
US 20110054310A1 · Taylor et al. · 2011 [cited by applicant]
US 20110196304A1 · Kramer et al. · 2011 [cited by applicant]
US 20110264136A1 · Choi et al. · 2011 [cited by applicant]
US 20110305376A1 · Neff · 2011 [cited by applicant]
US 20110317004A1 · Tao · 2011 [cited by applicant]
US 20120022443A1 · Robertson et al. · 2012 [cited by applicant]
US 20120024154A1 · Augustine et al. · 2012 [cited by applicant]
US 20120026308A1 · Johnson et al. · 2012 [cited by applicant]
US 20120154120A1 · Alloro et al. · 2012 [cited by applicant]
US 20120154582A1 · Johnson et al. · 2012 [cited by applicant]
US 20120177256A1 · Keefe et al. · 2012 [cited by applicant]
US 20120305787A1 · Henson · 2012 [cited by applicant]
US 20130041258A1 · Patrick et al. · 2013 [cited by applicant]
US 20130225945A1 · Prince et al. · 2013 [cited by applicant]
US 20130243647A1 · Garner et al. · 2013 [cited by applicant]
US 20130269714A1 · Roe et al. · 2013 [cited by applicant]
US 20130277430A1 · Zumsteg et al. · 2013 [cited by applicant]
US 20140081175A1 · Telfort · 2014 [cited by applicant]
US 20140194793A1 · Nakata · 2014 [cited by examiner]
US 20140262553A1 · Pollock et al. · 2014 [cited by applicant]
US 20150168207A1 · Pollock et al. · 2015 [cited by applicant]
US 20150209510A1 · Burkholz et al. · 2015 [cited by applicant]
US 20150220080A1 · Nixon et al. · 2015 [cited by applicant]
US 20150223890A1 · Miller et al. · 2015 [cited by applicant]
US 20150224237A1 · Reasoner et al. · 2015 [cited by applicant]
US 20150363566A1 · Johnson et al. · 2015 [cited by applicant]
US 20160001213A1 · Balcik · 2016 [cited by applicant]
US 20160042623A1 · Riley · 2016 [cited by examiner]
US 20160085922A1 · Sweeney · 2016 [cited by applicant]
US 20160103967A1 · Bulut et al. · 2016 [cited by applicant]
US 20160119593A1 · Schultz et al. · 2016 [cited by applicant]
US 20160125137A1 · Ott · 2016 [cited by applicant]
US 20160188831A1 · Kurtz et al. · 2016 [cited by applicant]
US 20160225144A1 · Spahn et al. · 2016 [cited by applicant]
US 20160247277A1 · Krihell et al. · 2016 [cited by applicant]
US 20160283691A1 · Ali · 2016 [cited by applicant]
US 20160362234A1 · Peret et al. · 2016 [cited by applicant]
US 20160379504A1 · Bailey et al. · 2016 [cited by applicant]
US 20170039227A1 · Herbst et al. · 2017 [cited by applicant]
US 20170095170A1 · Verkruijsse et al. · 2017 [cited by applicant]
US 20170112954A1 · Dayton · 2017 [cited by applicant]
US 20170140125A1 · Hogg · 2017 [cited by examiner]
US 20170142933A1 · Neskin et al. · 2017 [cited by applicant]
US 20170147787A1 · Albrecht et al. · 2017 [cited by applicant]
US 20170156661A1 · Hughes et al. · 2017 [cited by applicant]
US 20170173262A1 · Veltz · 2017 [cited by applicant]
US 20170185717A1 · Williams et al. · 2017 [cited by applicant]
US 20170209658A1 · Tobia et al. · 2017 [cited by applicant]
US 20170235913A1 · Aly et al. · 2017 [cited by applicant]
US 20170238842A1 · Jacquel et al. · 2017 [cited by applicant]
US 20170251990A1 · Kheradpir et al. · 2017 [cited by applicant]
US 20170262614A1 · Vishnubhatla et al. · 2017 [cited by applicant]
US 20170300385A1 · Huang · 2017 [cited by applicant]
US 20170326385A1 · Fishman · 2017 [cited by applicant]
US 20170333626A1 · Mansour · 2017 [cited by applicant]
US 20170337493A1 · Paramasivan et al. · 2017 [cited by applicant]
US 20180008787A1 · Schriver et al. · 2018 [cited by applicant]
US 20180036583A1 · Lagree et al. · 2018 [cited by applicant]
US 20180067484A1 · Troy et al. · 2018 [cited by applicant]
US 20180132966A1 · Desaulniers et al. · 2018 [cited by applicant]
US 20180169327A1 · Iddon et al. · 2018 [cited by applicant]
US 20180182475A1 · Cossler · 2018 [cited by examiner]
US 20180225346A1 · Liu et al. · 2018 [cited by applicant]
US 20180303574A1 · Ramirez Luna et al. · 2018 [cited by applicant]
US 20180353698A1 · Saint et al. · 2018 [cited by applicant]
US 20180365385A1 · Cooney · 2018 [cited by examiner]
US 20190057760A1 · Schwartz et al. · 2019 [cited by applicant]
US 20190105120A1 · Norman et al. · 2019 [cited by applicant]
US 20190183591A1 · Johnson et al. · 2019 [cited by applicant]
US 20190197466A1 · Hand, III et al. · 2019 [cited by applicant]
US 20190201126A1 · Shelton, IV et al. · 2019 [cited by applicant]
US 20190201158A1 · Shelton, IV et al. · 2019 [cited by applicant]
US 20190290524A1 · Augustine et al. · 2019 [cited by applicant]
US 20190294965A1 · Buhrmann et al. · 2019 [cited by applicant]
US 20190297745A1 · Augustine et al. · 2019 [cited by applicant]
US 20190328598A1 · Mangiardi · 2019 [cited by applicant]
US 20190333621A1 · Bengtsson et al. · 2019 [cited by applicant]
US 20190357382A1 · Augustine et al. · 2019 [cited by applicant]
US 20200004027A1 · Grootjans et al. · 2020 [cited by applicant]
US 20200038274A1 · Augustine et al. · 2020 [cited by applicant]
US 20200046590A1 · Augustine et al. · 2020 [cited by applicant]
US 20200121496A1 · Prokop et al. · 2020 [cited by applicant]
US 20200160057A1 · Roxas et al. · 2020 [cited by applicant]
US 20200230316A1 · Guerra et al. · 2020 [cited by applicant]
US 20200268315A1 · Burwinkel et al. · 2020 [cited by applicant]
US 20200273581A1 · Wolf et al. · 2020 [cited by applicant]
US 20200281790A1 · Augustine et al. · 2020 [cited by applicant]
US 20200286610A1 · Wartena · 2020 [cited by examiner]
US 20200289354A1 · Augustine et al. · 2020 [cited by applicant]
US 20200305713A1 · Sipe et al. · 2020 [cited by applicant]
US 20210052454A1 · Augustine et al. · 2021 [cited by applicant]
US 20210100710A1 · Augustine et al. · 2021 [cited by applicant]
US 20210196550A1 · Augustine et al. · 2021 [cited by applicant]
US 20210251835A1 · Augustine et al. · 2021 [cited by applicant]
US 20210316633A1 · Kalligeros et al. · 2021 [cited by applicant]
US 20210338510A1 · Augustine et al. · 2021 [cited by applicant]
US 20210338511A1 · Augustine et al. · 2021 [cited by applicant]
US 20210345954A1 · Shelton, IV et al. · 2021 [cited by applicant]
US 20210361507A1 · Augustine et al. · 2021 [cited by applicant]
US 20210361508A1 · Augustine et al. · 2021 [cited by applicant]
US 20210361509A1 · Augustine et al. · 2021 [cited by applicant]
US 20210375480A1 · Mahon et al. · 2021 [cited by applicant]
US 20220062084A1 · Augustine et al. · 2022 [cited by applicant]
US 20220071828A1 · Augustine et al. · 2022 [cited by applicant]
US 20220096305A1 · Augustine et al. · 2022 [cited by applicant]
US 20220104987A1 · Augustine et al. · 2022 [cited by applicant]
US 20220183915A1 · Augustine et al. · 2022 [cited by applicant]
US 20220202639A1 · Augustine et al. · 2022 [cited by applicant]
US 20220280085A1 · Retzkin et al. · 2022 [cited by applicant]
US 20220347031A1 · Augustine et al. · 2022 [cited by applicant]
US 20220354723A1 · Augustine et al. · 2022 [cited by applicant]
US 20220362085A1 · Augustine et al. · 2022 [cited by applicant]
US 20220362086A1 · Augustine et al. · 2022 [cited by applicant]
US 20220362087A1 · Augustine et al. · 2022 [cited by applicant]
US 20220362493A1 · White · 2022 [cited by applicant]
US 20220367020A1 · Augustine et al. · 2022 [cited by applicant]
US 20220370275A1 · Augustine et al. · 2022 [cited by applicant]
US 20230149236A1 · Augustine et al. · 2023 [cited by applicant]
US 20230149237A1 · Augustine et al. · 2023 [cited by applicant]
US 20230149238A1 · Augustine et al. · 2023 [cited by applicant]
US 20230149239A1 · Augustine et al. · 2023 [cited by applicant]
US 20230157918A1 · Augustine et al. · 2023 [cited by applicant]
US 20230233394A1 · Augustine et al. · 2023 [cited by applicant]
US 20230270609A1 · Augustine et al. · 2023 [cited by applicant]
US 20230270610A1 · Augustine et al. · 2023 [cited by applicant]
US 20230293374A1 · Augustine et al. · 2023 [cited by applicant]
US 20230293375A1 · Augustine et al. · 2023 [cited by applicant]
US 20230346621A1 · Augustine et al. · 2023 [cited by applicant]
US 20230346622A1 · Augustine et al. · 2023 [cited by applicant]
US 20230346623A1 · Augustine et al. · 2023 [cited by applicant]
US 20230355457A1 · Augustine et al. · 2023 [cited by applicant]
US 20230360790A1 · Burkholz et al. · 2023 [cited by applicant]
US 20230404830A1 · Augustine et al. · 2023 [cited by applicant]
US 20230414432A1 · Augustine et al. · 2023 [cited by applicant]
US 20230414433A1 · Augustine et al. · 2023 [cited by applicant]
US 20240207122A1 · Augustine et al. · 2024 [cited by applicant]
US 20240423857A1 · Augustine et al. · 2024 [cited by applicant]
CN 101980732A · 2011 [cited by applicant]
CN 109934097A · 2019 [cited by applicant]
EP 3103385A1 · 2016 [cited by applicant]
WO WO2016025989A1 · 2016 [cited by applicant]
WO WO2017161131A1 · 2017 [cited by applicant]
WO WO2019191081A1 · 2019 [cited by applicant]
WO WO2021236077A1 · 2021 [cited by applicant]
WO WO2021236182A1 · 2021 [cited by applicant]
WO WO2021236319A1 · 2021 [cited by applicant]
“U.S. Appl. No. 15/935,524, Corrected Notice of Allowability mailed Jul. 18, 2019”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Corrected Notice of Allowability mailed Aug. 21, 2019”2 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Non Final Office Action mailed Mar. 8, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Non Final Office Action mailed Sep. 19, 2018”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Notice of Allowance mailed Jun. 12, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Response filed May 15, 2019 to Non Final Office Action mailed Mar. 8, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 15/935,524, Response filed Dec. 12, 2018 to Non Final Office Action mailed Sep. 19, 2018”, 18 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Corrected Notice of Allowability mailed Aug. 29, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Corrected Notice of Allowability mailed Nov. 8, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Non Final Office Action mailed Jul. 3, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Notice of Allowance mailed Aug. 20, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Response filed Jun. 18, 2019 to Restriction Requirement mailed May 1, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Response filed Jul. 24, 2019 to Non Final Office Action mailed Jul. 3, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/364,884, Restriction Requirement mailed May 1, 2019”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/519,677, Non Final Office Action mailed Nov. 13, 2019”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/519,677, Response filed Dec. 17, 2019 to Non Final Office Action mailed Nov. 13, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/529,283, Corrected Notice of Allowability mailed Mar. 6, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/529,283, Non Final Office Action mailed Sep. 18, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/529,283, Notice of Allowance mailed Jan. 10, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/529,283, Response filed Dec. 13, 2019 to Non Final Office Action mailed Sep. 18, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/593,033, Notice of Allowance mailed Jan. 14, 2020”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/601,924, Non Final Office Action mailed Dec. 5, 2019”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/601,924, Notice of Allowance mailed Mar. 11, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/601,924, Response filed Feb. 26, 2020 to Non Final Office Action mailed Dec. 5, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/879,406, Corrected Notice of Allowability mailed Oct. 21, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/879,406, Non Final Office Action mailed Jun. 9, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/879,406, Notice of Allowance malled Sep. 10, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/879,406, Response filed Sep. 2, 2020 to Non Final Office Action mailed Jun. 9, 2020”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/885,715, Non Final Office Action mailed Jun. 23, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/885,715, Notice of Allowance mailed Sep. 22, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/885,715, Notice of Non-Compliant Amendment mailed Sep. 10, 2020”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/885,715, Response filed Sep. 2, 2020 to Non Final Office Action mailed Jun. 23, 2020”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/885,715, Response filed Sep. 14, 2020 to Notice of Non-Compliant Amendment mailed Sep. 10, 2020”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/092,681, Non Final Office Action mailed Dec. 17, 2020”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/092,681, Notice of Allowance mailed Feb. 2, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/092,681, Response filed Jan. 22, 2021 to Non Final Office Action mailed Dec. 17, 2020”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/103,426, Non Final Office Action mailed Jan. 25, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/103,426, Notice of Allowance mailed Mar. 12, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/103,426, Response filed Mar. 2, 2021 to Non Final Office Action mailed Jan. 25, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/167,681, Corrected Notice of Allowability mailed Sep. 21, 2021”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/167,681, Non Final Office Action mailed Apr. 5, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/167,681, Notice of Allowance mailed May 17, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/167,681, Notice of Allowance mailed Aug. 25, 2021”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/167,681, Response filed May 5, 2021 to Non Final Office Action mailed Apr. 5, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/199,722, Non Final Office Action mailed May 12, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/199,722, Notice of Allowance mailed Jul. 26, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/199,722, Preliminary Amendment filed Apr. 12, 2021”, 12. [cited by applicant]
“U.S. Appl. No. 17/199,722, Response filed Jul. 14, 2021 to Non Final Office Action mailed May 12, 2021”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Corrected Notice of Allowability mailed Aug. 2, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Final Office Action mailed Mar. 2, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Non Final Office Action mailed Jun. 30, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Non Final Office Action mailed Nov. 19, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Notice of Allowance mailed May 2, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Notice of Allowance mailed Jul. 27, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Response filed Feb. 15, 2022 to Non Final Office Action mailed Nov. 19, 2021”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Response filed Apr. 15, 2022 to Final Office Action mailed Mar. 2, 2022”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 17/245,942, Response filed Jul. 14, 2021 to Non Final Office Action malled Jun. 30, 2021”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/308,437, Non Final Office Action mailed Jul. 15, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/308,437, Notice of Allowance mailed Dec. 6, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/308,437, Response filed Nov. 10, 2021 to Non Final Office Action mailed Jul. 15, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/332,523, Non Final Office Action mailed Jul. 29, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/332,523, Notice of Allowance mailed Oct. 29, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/332,523, Response filed Sep. 29, 2021 to Non Final Office Action mailed Jul. 29, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/375,546, Non Final Office Action mailed Oct. 27, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/375,546, Notice of Allowance mailed Feb. 25, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/375,546, Response filed Jan. 27, 2022 to Non Final Office Action mailed Oct. 27, 2021”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/376,469, Non Final Office Action mailed Sep. 17, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/376,469, Notice of Allowance mailed Nov. 23, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/376,469, Response filed Sep. 29, 2021 to Non Final Office Action mailed Sep. 17, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Corrected Notice of Allowability mailed Jun. 2, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Final Office Action mailed Apr. 19, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Non Final Office Action mailed Jan. 13, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Notice of Allowance mailed May 3, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Response filed Apr. 13, 2022 to Non Final Office Action mailed Jan. 13, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/523,549, Response filed Apr. 19, 2022 to Final Office Action mailed Apr. 19, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/528,832, Final Office Action mailed Apr. 22, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/528,832, Non Final Office Action mailed Feb. 8, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/528,832, Notice of Allowance mailed Jun. 29, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/528,832, Response filled Apr. 15, 2022 to Non Final Office Action mailed Feb. 8, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/528,832, Response filed Jun. 20, 2022 to Final Office Action mailed Apr. 22, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,611, Corrected Notice of Allowability mailed May 4, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,611, Corrected Notice of Allowability mailed Jul. 15, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,611, Non Final Office Action mailed Feb. 10, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,611, Notice of Allowance mailed Apr. 25, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,611, Response filed Apr. 15, 2022 to Non Final Office Action mailed Feb. 10, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,696, Corrected Notice of Allowability mailed Aug. 8, 2022”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,696, Non Final Office Action mailed Feb. 10, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,696, Notice of Allowance mailed May 17, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/550,696, Response filed May 9, 2022 to Non Final Office Action mailed Feb. 10, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Final Office Action mailed Jun. 3, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Non Final Office Action mailed May 13, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Notice of Allowance mailed Aug. 11, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Preliminary Amendment filed Apr. 7, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Response filed May 23, 2022 to Non Final Office Action mailed May 13, 2022”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Response filed Aug. 1, 2022 to Final Office Action mailed Jun. 3, 2022”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/678,550, Supplemental Amendment filed Aug. 2, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/697,398, Non Final Office Action mailed May 27, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/697,398, Notice of Allowance mailed Aug. 19, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/697,398, Response filed Aug. 2, 2022 to Non Final Office Action mailed May 27, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/862,971, Non Final Office Action mailed Nov. 15, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/862,971, Notice of Allowance mailed Nov. 20, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/862,971, Notice of Allowance mailed Dec. 20, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/862,971, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 15, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,857, Corrected Notice of Allowability mailed Apr. 13, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,857, Non Final Office Action mailed Nov. 14, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,857, Notice of Allowance mailed Dec. 21, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,857, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 14, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,857, Supplemental Notice of Allowability mailed Mar. 14, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,907, Final Office Action mailed Dec. 13, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,907, Non Final Office Action mailed Nov. 14, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,907, Notice of Allowance mailed Jan. 25, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,907, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 14, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,907, Response filed Dec. 14, 2022 to Final Office Action mailed Dec. 13, 2022”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,975, Non Final Office Action mailed Nov. 15, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,975, Notice of Allowance mailed Dec. 21, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/873,975, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 15, 2022”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,963, Corrected Notice of Allowability mailed Apr. 13, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,963, Non Final Office Action mailed Nov. 14, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,963, Notice of Allowance mailed Dec. 21, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,963, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 14, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,963, Supplemental Notice of Allowability mailed Mar. 14, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,998, Non Final Office Action malled Nov. 15, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,998, Notice of Allowance mailed Dec. 16, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/874,998, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 15, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/875,055, Non Final Office Action mailed Nov. 15, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/875,055, Notice of Allowance mailed Dec. 22, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/875,055, Response filed Dec. 5, 2022 to Non Final Office Action mailed Nov. 15, 2022”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 18/092,532, Non Final Office Action mailed Apr. 14, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/092,532, Notice of Allowance mailed May 24, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/092,532, Response filed Apr. 27, 2023 to Non Final Office Action mailed Apr. 14, 2023”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,074, Non Final Office Action mailed Apr. 17, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,074, Non Final Office Action mailed Oct. 20, 2023”, 90 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,074, Notice of Allowance malled Aug. 7, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,074, Response filed Jul. 13, 2023 to Non Final Office Action mailed Apr. 17, 2023”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,475, Corrected Notice of Allowability mailed Apr. 19, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,475, Non Final Office Action mailed Mar. 8, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,475, Notice of Allowance mailed Apr. 4, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,475, Response filed Mar. 17, 2023 to Non Final Office Action mailed Mar. 8, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,500, Notice of Allowance mailed May 5, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,557, Corrected Notice of Allowability mailed Apr. 14, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,557, Non Final Office Action mailed Mar. 6, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,557, Notice of Allowance mailed Apr. 5, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/099,557, Response filed Mar. 17, 2023 to Non Final Office Action mailed Mar. 6, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 18/136,141, Corrected Notice of Allowability mailed Aug. 16, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/136,141, Non Final Office Action mailed Jun. 12, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/136,141, Notice of Allowance mailed Jul. 11, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/136,141, Preliminary Amendment filed Apr. 18, 2023”. [cited by applicant]
“U.S. Appl. No. 18/136,141, Response filed Jun. 28, 2023 to Non Final Office Action mailed Jun. 12, 2023”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,776, Non Final Office Action mailed Jun. 13, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,776, Notice of Allowance mailed Jul. 19, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,776, Response filed Jun. 28, 2023 to Non Final Office Action mailed Jun. 13, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Non Final Office Action mailed Jan. 24, 2024”, 23 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Non Final Office Action mailed Aug. 4, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Notice of Allowance mailed Mar. 6, 2024”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Notice of Allowance mailed Aug. 30, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Response filed Feb. 22, 2024 to Non Final Office Action mailed Jan. 24, 2024”, 15 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Response filed Aug. 21, 2023 to Non Final Office Action mailed Aug. 4, 2023”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 18/142,787, Supplemental Notice of Allowability mailed May 20, 2024”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 18/191,115, Non Final Office Action mailed Jun. 12, 2023”, 7 pgs. [cited by applicant]
Cited By (1)
US 12,697,266